Pathogenic role of cGAS-STING pathway in Duchenne muscular dystrophy

The cGAS-STING pathway is a critical component of the innate immune response to infection and cell stress. Chronic activation underlies human diseases such as lupus and inflammatory bowel disease, but cGAS-STING has not been implicated in Duchenne muscular dystrophy (DMD). Compared to healthy controls, macrophages from DMD patients have high levels of cytosolic DNA and low levels of the DNA exonuclease, TREX1, a scavenger of cytosolic DNA upstream of cGAS-STING. Likewise, cytosolic DNA is elevated in macrophages from dystrophin-deficient mdx mice. Such macrophages over-produce cGAMP and secrete it locally, activating STING in neighboring myoblasts and thereby suppressing myogenesis. TY1, a synthetic non-coding RNA drug that enhances TREX1, attenuates cGAS-STING and restores cellular and tissue homeostasis in mdx mice. When administered intravenously or orally, TY1 not only halted disease progression but actually reversed cardiac and skeletal muscle pathology. Thus, pathological activation of cGAS-STING by cytosolic DNA mediates disease progression in DMD. Our work identifies TREX1, cGAS and STING as novel therapeutic targets in muscular dystrophy.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.13.766546
Primary Topic
Muscle Physiology and Disorders
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pathogenic role of cGAS-STING pathway in Duchenne muscular dystrophy

Mario Fournier, Adarsh Balaji, Jonah E. Zarrow, Alice Rannou et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Muscle Physiology and Disorders
preprint

Pathogenic role of cGAS-STING pathway in Duchenne muscular dystrophy

Mario Fournier, Adarsh Balaji, Jonah E. Zarrow, Alice Rannou, Russell George Rogers, Eduardo Marbán, Jocelyn Alfaro, Sankalpa Chakraborty, Nancy Manriquez, Weixin Liu, Ahmed Ibrahim, Sophia Kangavari
preprint en

Abstract

The cGAS-STING pathway is a critical component of the innate immune response to infection and cell stress. Chronic activation underlies human diseases such as lupus and inflammatory bowel disease, but cGAS-STING has not been implicated in Duchenne muscular dystrophy (DMD). Compared to healthy controls, macrophages from DMD patients have high levels of cytosolic DNA and low levels of the DNA exonuclease, TREX1, a scavenger of cytosolic DNA upstream of cGAS-STING. Likewise, cytosolic DNA is elevated in macrophages from dystrophin-deficient mdx mice. Such macrophages over-produce cGAMP and secrete it locally, activating STING in neighboring myoblasts and thereby suppressing myogenesis. TY1, a synthetic non-coding RNA drug that enhances TREX1, attenuates cGAS-STING and restores cellular and tissue homeostasis in mdx mice. When administered intravenously or orally, TY1 not only halted disease progression but actually reversed cardiac and skeletal muscle pathology. Thus, pathological activation of cGAS-STING by cytosolic DNA mediates disease progression in DMD. Our work identifies TREX1, cGAS and STING as novel therapeutic targets in muscular dystrophy.

bioRxiv (Cold Spring Harbor Laboratory)
Cedars-Sinai Medical Center (US), Cedars-Sinai Smidt Heart Institute (US)
Cedars-Sinai Medical Center, National Institutes of Health, National Heart, Lung, and Blood Institute
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon